Blocking blood flow before surgery may help remove inoperable bile duct cancer

NCT ID NCT07326189

Not yet recruiting Disease control Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether blocking the artery that feeds a bile duct tumor before surgery can make it possible to remove the cancer safely. It includes 33 adults with advanced bile duct cancer that currently cannot be operated on. The main goal is to see how many patients are alive one year after the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Preoperative right hepatic artery embolization (a procedure to block the artery feeding the tumor)
What this could lead to: If it works, this could offer a surgical option for patients with advanced bile duct cancer that is currently considered inoperable.
What could go wrong: This is a small, early-phase study with only 33 people, so results may not apply widely. The procedure carries risks like bleeding or infection, and the cancer may still return.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA NON-RESECTABLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholangiocarcinoma hilar cholangiocarcinoma perihilar intrahepatic cholangiocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLANGIOCARCINOMA NON-RESECTABLE

More trials for these conditions

Other studies related to the condition(s) this trial covers.